Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 38 5 IN PLASTIC CONTAINER versus DEXTROSE 5.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 38 5 IN PLASTIC CONTAINER versus DEXTROSE 5.
DEXTROSE 38.5% IN PLASTIC CONTAINER vs DEXTROSE 5%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a simple sugar that provides caloric support and serves as a source of energy. It increases blood glucose levels, which is essential for cellular metabolism, particularly in the brain and erythrocytes.
Dextrose 5% provides a source of calories and water for intravenous administration. It is metabolized to carbon dioxide and water, yielding energy. Dextrose solutions exert osmotic effects and can increase blood glucose levels.
Intravenous administration. Dose depends on clinical condition; typically 50-100 mL of 38.5% dextrose (19.25-38.5 g glucose) for hypoglycemia. Maximum infusion rate: 0.5 g/kg/h.
Intravenous infusion; 5% dextrose in water (D5W) is typically administered at a rate of 100-200 mL/hour to provide 50-100 g of glucose per day for maintenance hydration and minimal caloric support in adults.
None Documented
None Documented
~30 minutes (endogenous glucose turnover; clinical context: continuous infusion required for maintenance as glucose is rapidly metabolized)
0.5-1 hour (endogenous glucose); intravenous infusion half-life is variable due to continuous cellular uptake and metabolism; clinical context: rapid clearance via insulin-mediated cellular uptake and glycolysis.
100% renal (excreted as carbon dioxide and water after metabolism; negligible unchanged glucose in urine under normoglycemia; renal threshold ~180 mg/dL)
Renal: 100% (D-glucose and its metabolites, including CO2 and water); less than 1% excreted unchanged in urine under normal conditions; fecal excretion negligible.
Category C
Category C
IV Fluid
IV Fluid